Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis
Clinical trial NCT01273779 · SUSPENDED
Trial details
- NCT number
- NCT01273779
- Sponsor
- Agennix
- Status
- SUSPENDED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2014-01-01
- Enrollment
- 1280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.